Rautava Samuli, Isolauri Erika
Department of Paediatrics, University of Turku, Finland.
Curr Issues Intest Microbiol. 2002 Mar;3(1):15-22.
The infant's immature intestinal immune system develops as it comes into contact with dietary and microbial antigens in the gut. The evolving indigenous intestinal microbiota have a significant impact on the developing immune system and there is accumulating evidence indicating that an intimate interaction between gut microbiota and host defence mechanisms is mandatory for the development and maintenance of a balance between tolerance to innocuous antigens and capability of mounting an inflammatory response towards potential pathogens. Disturbances in the mucosal immune system are reflected in the composition of the gut microbiota and vice versa. Distinctive alterations in the composition of the gut microbiota appear to precede the manifestation of atopic disease, which suggests a role for the interaction between the intestinal immune system and specific strains of the microbiota in the pathogenesis of allergic disorders. The administration of probiotics, strains of bacteria from the healthy human gut microbiota, have been shown to stimulate antiinflammatory, tolerogenic immune responses, the lack of which has been implied in the development of atopic disorders. Thus probiotics may prove beneficial in the prevention and alleviation of allergic disease.
婴儿不成熟的肠道免疫系统在其接触肠道中的饮食和微生物抗原时逐渐发育。不断演变的本土肠道微生物群对发育中的免疫系统有重大影响,并且有越来越多的证据表明,肠道微生物群与宿主防御机制之间的密切相互作用对于在对无害抗原的耐受性和对潜在病原体产生炎症反应的能力之间维持平衡的发育和维持是必不可少的。黏膜免疫系统的紊乱反映在肠道微生物群的组成中,反之亦然。肠道微生物群组成的明显改变似乎在特应性疾病表现之前出现,这表明肠道免疫系统与微生物群的特定菌株之间的相互作用在过敏性疾病的发病机制中起作用。已证明施用益生菌(来自健康人类肠道微生物群的细菌菌株)可刺激抗炎、耐受性免疫反应,而特应性疾病的发展中则暗示缺乏这种反应。因此,益生菌可能在预防和减轻过敏性疾病方面被证明是有益的。